terfenadine has been researched along with taurocholic acid in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Bian, S; Chung, SJ; Gebhardt, M; Kim, DD; Kwon, KA; Lin, H; Shim, CK | 1 |
Davis, CB; Dawson, PA; Garver, E; Han, C; Hugger, ED; Rao, A; Shearn, SP | 1 |
Cho, HJ; Choi, MK; Chung, SJ; Huh, Y; Kim, DD; Kim, JS; Oh, E; Shim, CK; Yoon, IS | 1 |
5 other study(ies) available for terfenadine and taurocholic acid
Article | Year |
---|---|
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Enhancing effect of surfactants on fexofenadine.HCl transport across the human nasal epithelial cell monolayer.
Topics: Cell Membrane Permeability; Cell Survival; Drug Synergism; Epithelial Cells; Formazans; Histamine H1 Antagonists, Non-Sedating; Humans; Microscopy, Confocal; Nasal Mucosa; Poloxamer; Polysorbates; Sodium Cholate; Surface-Active Agents; Taurocholic Acid; Terfenadine; Tetrazolium Salts | 2007 |
Involvement of intestinal uptake transporters in the absorption of azithromycin and clarithromycin in the rat.
Topics: Administration, Oral; Animals; Antirheumatic Agents; Area Under Curve; Azithromycin; Biological Transport, Active; Cell Line; Clarithromycin; Dogs; Histamine H1 Antagonists, Non-Sedating; Infusions, Intravenous; Intestinal Absorption; Male; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Rats; Rats, Sprague-Dawley; Rifamycins; Taurocholic Acid; Terfenadine; Transfection | 2008 |
Preparation and evaluation of spray-dried hyaluronic acid microspheres for intranasal delivery of fexofenadine hydrochloride.
Topics: Administration, Intranasal; Animals; Anti-Allergic Agents; Area Under Curve; Biological Availability; Cell Line; Drug Carriers; Electric Impedance; Epithelial Cells; Humans; Hyaluronic Acid; Microscopy, Electron, Scanning; Microspheres; Particle Size; Permeability; Polyethylene Glycols; Rabbits; Respiratory Mucosa; Surface Properties; Taurocholic Acid; Terfenadine | 2010 |